Outcomes in patients tested for Clostridium difficile toxins

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Clinical Diagnostics

Background:

• Clostridium difficile testing is transitioning from toxin detection to direct C. difficile detection.
• A significant proportion of patients (up to 60%) test negative for toxins despite positive C. difficile cultures, creating diagnostic uncertainty regarding infection versus carrier status.

Purpose of the Study:

• To compare the duration of diarrhea, complication rates, and mortality between toxin-positive and toxin-negative patients.
• To assess the clinical significance of C. difficile detection in toxin-negative individuals.

Main Methods:

• Retrospective review of medical records for 7046 inpatients tested for C. difficile toxins between 2005 and 2009.
• Analysis of diarrhea duration, complication rates (including pseudomembranous colitis, megacolon, colectomy), and mortality.

Main Results:

• Toxin-negative patients exhibited significantly less severe diarrhea, fewer diarrhea days, and lower mortality compared to toxin-positive patients (P < 0.001).
• Pseudomembranous colitis was rare in toxin-negative patients (0.02%), with no cases of fulminant C. difficile infection complications like megacolon or colectomy.

Conclusions:

• C. difficile-associated complications appear infrequent in patients who test negative for C. difficile toxins.
• Further investigation is warranted to clarify the clinical implications of detecting C. difficile in toxin-negative patient populations.